PA Biotechnology
PA Biotechnology develops in vitro tissue and disease models and laboratory testing services focused on reducing animal testing and providing safety data for cosmetics, pharmaceuticals and chemicals. The company provides standardized in vitro assays, custom model and test‑kit development (including microfluidic approaches), and reporting workflows intended to support product safety evaluation and R&D.
Industries
Nr. of Employees
small (1-50)
PA Biotechnology
Erzene Neighborhood, Ankara Street, Ebiltem Building No:172/14, 35040 Bornova / Izmir
Products
In vitro skin irritation test kit (under development)
A laboratory test kit intended to evaluate skin irritation potential using in vitro skin models; listed as a forthcoming product.
Microfluidic-based in vitro skin irritation test kit (in development)
A microfluidic implementation of an in vitro skin irritation test kit intended to provide refined, miniaturized irritation assessments.
In vitro skin irritation test kit (under development)
A laboratory test kit intended to evaluate skin irritation potential using in vitro skin models; listed as a forthcoming product.
Microfluidic-based in vitro skin irritation test kit (in development)
A microfluidic implementation of an in vitro skin irritation test kit intended to provide refined, miniaturized irritation assessments.
Services
Laboratory execution of OECD 439 in vitro skin irritation assays using reconstructed epidermis to evaluate irritation potential of formulations and ingredients.
Execution of OECD 431 assays using reconstructed human epidermis to assess irreversible skin damage potential for chemicals and products.
In vitro phototoxicity assessment using reconstructed epidermis and UV exposure to determine phototoxic risk of substances.
In vitro cytotoxicity assays measuring effects of test substances on cultured cells to identify toxic responses during product development.
In vitro genotoxicity evaluations to detect genetic damage potential of compounds and formulations.
Scratch/migration assays and diabetic wound healing models to evaluate regenerative and reparative effects of treatments or biomaterials.
Laboratory execution of OECD 439 in vitro skin irritation assays using reconstructed epidermis to evaluate irritation potential of formulations and ingredients.
Execution of OECD 431 assays using reconstructed human epidermis to assess irreversible skin damage potential for chemicals and products.
In vitro phototoxicity assessment using reconstructed epidermis and UV exposure to determine phototoxic risk of substances.
In vitro cytotoxicity assays measuring effects of test substances on cultured cells to identify toxic responses during product development.
In vitro genotoxicity evaluations to detect genetic damage potential of compounds and formulations.
Scratch/migration assays and diabetic wound healing models to evaluate regenerative and reparative effects of treatments or biomaterials.
Expertise Areas
- In vitro assay development
- Toxicology testing for cosmetics and chemicals
- Biomaterials and tissue engineering
- Microfluidic and organ‑on‑chip development
Key Technologies
- Reconstructed human epidermis (RhE) models
- 2D and 3D cell culture
- Organ‑on‑chip / microfluidics
- In vitro wound healing (scratch) assays
News & Updates
Exhibited ethical alternative testing solutions and sustainability-focused approaches at BIOEXPO 2025; engaged with researchers and industry stakeholders.
Presented biotechnology and in vitro test system solutions at EGE D-TECH DEMO DAY organized by EGE Teknopark.
Selected for support by the Small and Medium Enterprises Development Organization of Turkey (KOSGEB) to accelerate R&D and laboratory capability development.
Awarded second place in the Pre‑Incubation category at the Women in Innovation Entrepreneurship Camp.
Exhibited ethical alternative testing solutions and sustainability-focused approaches at BIOEXPO 2025; engaged with researchers and industry stakeholders.
Presented biotechnology and in vitro test system solutions at EGE D-TECH DEMO DAY organized by EGE Teknopark.
Selected for support by the Small and Medium Enterprises Development Organization of Turkey (KOSGEB) to accelerate R&D and laboratory capability development.
Awarded second place in the Pre‑Incubation category at the Women in Innovation Entrepreneurship Camp.